CIBC Private Wealth Group’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$32.8K Buy
2,779
+11
+0.4% +$141 ﹤0.01% 1961
2025
Q3
$43.8K Hold
2,768
﹤0.01% 1854
2025
Q2
$31.7K Sell
2,768
-509
-16% -$5.74K ﹤0.01% 1847
2025
Q1
$31.4K Sell
3,277
-14
-0.4% -$233 ﹤0.01% 1809
2024
Q4
$58.9K Buy
3,291
+1
+0% +$19 ﹤0.01% 1622
2024
Q3
$66.9K Hold
3,290
﹤0.01% 1665
2024
Q2
$73.4K Sell
3,290
-6
-0.2% -$157 ﹤0.01% 1515
2024
Q1
$94.7K Buy
+3,296
New +$93.9K ﹤0.01% 1419
2019
Q2
Sell
-36,886
Closed -$1.37M 922
2019
Q1
$1.37M Sell
36,886
-3,809
-9% -$139K 0.01% 536
2018
Q4
$1.15M Buy
40,695
+3,464
+9% +$110K 0.01% 542
2018
Q3
$1.47M Buy
37,231
+7,412
+25% +$324K 0.01% 592
2018
Q2
$1.32M Buy
29,819
+8,401
+39% +$418K 0.01% 597
2018
Q1
$1.04M Buy
21,418
+20,618
+2,577% +$1.03M ﹤0.01% 637
2017
Q4
$40K Buy
+800
New +$41.9K ﹤0.01% 1232

Other funds holding CC

CIBC Private Wealth Group's CC Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Chemours (CC) stake by 0.4% in Q4 2025, buying an estimated $141 and bringing the position to 2,779 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1961.

CIBC Private Wealth Group first reported a position in CC in Q4 2017 and has held it in 14 quarters since. The position peaked at $1.47M in Q3 2018. 435 funds tracked by Wall St. Rank hold CC as of Q4 2025.

  • CIBC Private Wealth Group held 2,779 shares of Chemours worth $32.8K as of Q4 2025.
  • CIBC Private Wealth Group bought 11 Chemours shares in Q4 2025, an estimated $141.
  • Chemours made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1961 holding.
  • CIBC Private Wealth Group first reported a position in Chemours in Q4 2017 and has held it in 14 quarters since.
  • CIBC Private Wealth Group's Chemours position peaked at $1.47M in Q3 2018.
  • 435 funds tracked by Wall St. Rank held Chemours as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.